A leap forward for biopharmaceutical services

The growing promise of biopharmaceuticals opens significant commercial opportunities for drug developers. At the same time, it also increases the pressure to rapidly bring candidates to the clinic and products to market.

Key challenges influencing this process include the need to maintain high productivity, product quality and reproducibility as you move from the research phase into clinical and commercial manufacturing. A successful outcome will often require significant technical expertise and advanced development and manufacturing technologies.

More than 30 years of experience in mammalian cell culture

Get access to a wide range of contract development and manufacturing services from vector construction, cell line and process development, process optimization, and manufacture from small to large scale.

Industry leading technologies

The GS Xceed® Gene Expression System is familiar to many regulatory agencies. This expression and manufacturing platform enables the production of high-quality cGMP products in a time- and cost-effective way. This can improve speed to the clinic or market while helping to reduce the costs and delays associated with low yields and poor batch quality.

We work in partnership with customers of all sizes, from start-ups to large biotechs and pharmaceutical companies, and can tailor our products and services to your specific needs, budget and timelines.


Your next therapy, let’s take it from concept to patient together.

Watch the video to learn more.

Phase-appropriate services

Whether you would like to work together on a complete gene to IND development program, a complete BLA program or on a specific subset of individual work packages, including commercial manufacturing, we have the expertise to help you achieve your goals.

No results available

Ibex™ Solutions

Ibex™ Solutions has been developed as a response to this dynamic market and your evolving needs. To help you take your drug candidates to clinics and market quickly. To streamline your supply. To increase predictability and manage risk. The services in Ibex™ Solutions give you the flexibility you need to deal with uncertainty, at every stage.


A global network of biopharmaceutical sites

We produce mammalian-derived biopharmaceuticals in highly advanced cGMP multi-product facilities, in a global network across three continents: Slough (UK), Hayward (US), Guangzhou (China), Portsmouth (US), Porriño (Spain), Tuas (Singapore) and Visp (Switzerland).

Slough, UK

Production, Research & Development, Sales & Support

228 Bath Road
Berkshire SL1 4DX
United Kingdom of Great Britain and Northern Ireland (the)

Hayward, CA, USA


1978 W Winton Ave
Hayward, CA 94545
United States of America (the)

Guangzhou, China

Production, Sales & Support

No.1, Kangji Road
Huangpu District
Guangzhou 510555, Guangdong Province

Portsmouth, NH, USA

Clinical Manufacturing, Commercial Manufacturing, Cell and Gene Manufacturing

101 International Drive
Portsmouth, NH 03801
United States of America (the)

Porriño, Spain



Singapore (Mammalian and Cell & Gene Technology)

Production, Sales & Support

Lonza Biologics Tuas Pte Ltd
Lonza Bioscience Singapore Pte Ltd
35 Tuas South Ave 6, Tuas 637377

Visp, Switzerland

Production, Research & Development, Sales & Support

Visp 3930